Chemoinformaics analysis of 2-(8,11,14-Heptadecatrienyl)-6-hydroxybenzoic acid
| Molecular Weight | 370.533 | nRot | 14 |
| Heavy Atom Molecular Weight | 336.261 | nRig | 10 |
| Exact Molecular Weight | 370.251 | nRing | 1 |
| Solubility: LogS | -2.976 | nHRing | 0 |
| Solubility: LogP | 6.862 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 65.157 |
| nHD | 2 | BPOL | 34.977 |
| QED | 0.279 |
| Synth | 2.738 |
| Natural Product Likeliness | 1.221 |
| NR-PPAR-gamma | 0.975 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.024 |
| CACO-2 | -5.196 |
| MDCK | 0.0000221 |
| BBB | 0.002 |
| PPB | 1.0119 |
| VDSS | 0.177 |
| FU | 0.0051 |
| CYP1A2-inh | 0.371 |
| CYP1A2-sub | 0.166 |
| CYP2c19-inh | 0.379 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.584 |
| CYP2c9-sub | 0.979 |
| CYP2d6-inh | 0.87 |
| CYP2d6-sub | 0.495 |
| CYP3a4-inh | 0.246 |
| CYP3a4-sub | 0.028 |
| CL | 1.526 |
| T12 | 0.845 |
| hERG | 0.111 |
| Ames | 0.002 |
| ROA | 0.008 |
| SkinSen | 0.947 |
| Carcinogencity | 0.033 |
| EI | 0.954 |
| Respiratory | 0.917 |
| NR-Aromatase | 0.182 |
| Antiviral | Yes |
| Prediction | 0.591013 |